
Top-ranked men's tennis player Jannik Sinner is set to participate in the upcoming U.S. Open in New York, despite revelations that he tested positive twice for the banned anabolic steroid Clostebol in March. The news of Sinner's positive tests only surfaced recently, sparking questions and criticism from fellow players regarding potential double standards and the handling of the situation.